These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19264852)

  • 1. Some notes on visinin-like protein 1 and Alzheimer disease.
    Bernstein HG; Braunewell KH
    Clin Chem; 2009 May; 55(5):1041-3. PubMed ID: 19264852
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid biomarkers in the evaluation of Alzheimer disease.
    Verbeek MM; Olde Rikkert MG
    Clin Chem; 2008 Oct; 54(10):1589-91. PubMed ID: 18824570
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease.
    Mroczko B; Groblewska M; Zboch M; Muszyński P; Zajkowska A; Borawska R; Szmitkowski M; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2015; 43(3):1031-7. PubMed ID: 25159667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of cerebrospinal fluid visinin-like protein-1 in alzheimers disease patients relative to healthy controls and mild cognitive impairment patients.
    Hu X; Yang Y; Gong D
    Neurosciences (Riyadh); 2017 Apr; 22(2):94-101. PubMed ID: 28416790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
    Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM
    JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Kirkwood CM; MacDonald ML; Schempf TA; Vatsavayi AV; Ikonomovic MD; Koppel JL; Ding Y; Sun M; Kofler JK; Lopez OL; Yates NA; Sweet RA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):175-82. PubMed ID: 26769253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
    Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis.
    Dhiman K; Blennow K; Zetterberg H; Martins RN; Gupta VB
    Cell Mol Life Sci; 2019 May; 76(10):1833-1863. PubMed ID: 30770953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.
    Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y
    J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.
    Höglund K; Kern S; Zettergren A; Börjesson-Hansson A; Zetterberg H; Skoog I; Blennow K
    Transl Psychiatry; 2017 Jan; 7(1):e995. PubMed ID: 28072416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visinin-like protein-1 in concussed professional ice hockey players.
    Shahim P; Mattsson N; Macy EM; Crimmins DL; Ladenson JH; Zetterberg H; Blennow K; Tegner Y
    Brain Inj; 2015; 29(7-8):872-6. PubMed ID: 25955117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel brain biomarkers.
    Laterza OF; Modur VR; Crimmins DL; Olander JV; Landt Y; Lee JM; Ladenson JH
    Clin Chem; 2006 Sep; 52(9):1713-21. PubMed ID: 16858073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
    Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
    JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    Muszyński P; Kulczyńska-Przybik A; Borawska R; Litman-Zawadzka A; Słowik A; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Mroczko B
    J Alzheimers Dis; 2017; 59(3):903-912. PubMed ID: 28697565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.
    Groblewska M; Muszyński P; Wojtulewska-Supron A; Kulczyńska-Przybik A; Mroczko B
    J Alzheimers Dis; 2015; 47(1):17-32. PubMed ID: 26402751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal EF-hand calcium-binding protein visinin-like protein-3 is expressed in cerebellar Purkinje cells and shows a calcium-dependent membrane association.
    Spilker C; Richter K; Smalla KH; Manahan-Vaughan D; Gundelfinger ED; Braunewell KH
    Neuroscience; 2000; 96(1):121-9. PubMed ID: 10683417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
    Schnurra I; Bernstein HG; Riederer P; Braunewell KH
    Neurobiol Dis; 2001 Oct; 8(5):900-9. PubMed ID: 11592857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preanalytical variables and Alzheimer disease biomarker concentrations in cerebrospinal fluid.
    Florkowski CM
    Clin Chem; 2015 May; 61(5):686-8. PubMed ID: 25869576
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairment.
    Dean RA; Shaw LM
    Clin Chem; 2010 Jan; 56(1):7-9. PubMed ID: 19926774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.